U.S. Markets open in 3 hrs, 55 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 4.10 12:05 PM EST | |
|---|---|---|
| Day High | 4.20 10:18 AM EST |
|
| Range | 0.10 |
| Volume | 3,400 | |
|---|---|---|
| 30-Day Avg Vol | 23,000 |
|
| Difference | -85.22% |
| Market Cap | 76.06 M | |
|---|---|---|
| Mkt Cap Chg | 1.81 M |
| Shares Out | 18.11 M | |
|---|---|---|
| % Shrs Traded | 0.02% | |
| 1yr EPS Est | -1.455 |
| 52-Wk Low | 1.00 | |
|---|---|---|
| 52-Wk High | 6.75 |
|
| Range | 5.75 |
| Prev Close | 4.10 11/5/09 | |
|---|---|---|
| Today's Open | 4.20 | |
| Change | 2.44% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 40,665.00 |
| Revenue (LFY) | 16.46 M | |
|---|---|---|
| Earnings (LFY) | -25.56 M | |
| Earnings (MRQ) | -6.70 M | |
| Next Earn Est | -0.195 | |
| Next Earnings | 03/08/2010 |
|
| EPS (TTM) | -1.71 | |
| 1yr EPS Growth | 12.87% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -2.00 | |
| PEG Ratio | — | |
| Return on Equity | -60.13 | |
| Beta | 1.98 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Trubion Pharmaceuticals' aim is TRU. The company is developing TRU-015, a clinical-stage drug for the treatment of autoimmune diseases including rheumatoid arthritis (currently in late-stage clinical trials) ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.195 3/8/10 | — — |
—
—
|
| Last Quarter | -0.43 9/30/09 | -0.33 9/30/09 |
0.10
Beat
|
| 2 Quarters Ago | -0.42 6/30/09 | -0.37 6/30/09 |
0.05
Beat
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 4.12 M | 16.47 M |
| Gross Profit | -2.57 M | -15.14 M |
| Operating Income | -6.60 M | -26.52 M |
| Net Income | -6.70 M | -25.56 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts